Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in …

S Garcia, Y Sandoval, H Roukoz, S Adabag… - Journal of the American …, 2013 - jacc.org
Objectives : This study sought to perform a systematic review and meta-analysis of studies
comparing complete revascularization (CR) versus incomplete revascularization (IR) in …

Device therapy and arrhythmia management in left ventricular assist device recipients: a scientific statement from the American Heart Association

…, CR Ellis, KT Hickey, JA Joglar, FD Pagani, H Roukoz… - Circulation, 2019 - Am Heart Assoc
Left ventricular assist devices (LVADs) are an increasingly used strategy for the management
of patients with advanced heart failure with reduced ejection fraction. Although these …

Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations in acute promyelocytic leukemia: a systematic review

A Beitinjaneh, S Jang, H Roukoz, NS Majhail - Leukemia research, 2010 - Elsevier
The fms-like tyrosine kinase 3 (FLT3) gene aberrations, internal tandem duplication (ITD)
and tyrosine kinase domain (TKD) mutations, are frequent in acute promyelocytic leukemia (…

Implantable cardioverter-defibrillator use in patients with left ventricular assist devices: a systematic review and meta-analysis

…, EL Kiehl, R Koene, R Cogswell, I Anand, H Roukoz - JACC: Heart Failure, 2016 - jacc.org
Objectives : This study evaluated the impact of implantable cardioverter-defibrillators (ICDs)
on mortality in patients with left ventricular assist devices (LVADs) by conducting a …

Assessment of the 2017 AHA/ACC/HRS guideline recommendations for implantable cardioverter-defibrillator implantation in cardiac sarcoidosis

…, S Adabag, L Von Wald, H Roukoz… - Circulation …, 2019 - Am Heart Assoc
Background: Implantable cardioverter-defibrillators are used to prevent sudden cardiac
death in patients with cardiac sarcoidosis. The most recent recommendations for implantable …

Cardiac resynchronization therapy in patients with minimal heart failure: a systematic review and meta-analysis

S Adabag, H Roukoz, IS Anand, AJ Moss - Journal of the American College …, 2011 - jacc.org
Objectives : The purpose of this study was to perform a systematic review and meta-analysis
of prospective randomized clinical trials of cardiac resynchronization therapy (CRT) versus …

Right ventricular abnormalities on cardiovascular magnetic resonance imaging in patients with sarcoidosis

…, F Kazmirczak, O Okasha, L von Wald, H Roukoz… - Cardiovascular …, 2020 - jacc.org
Objectives This study aimed to determine the prevalence on cardiac magnetic resonance (CMR)
of right ventricular (RV) systolic dysfunction and RV late gadolinium enhancement (LGE)…

Outcomes associated with catheter ablation of ventricular tachycardia in patients with cardiac sarcoidosis

…, AB Chicos, K Soejima, H Roukoz… - JAMA …, 2022 - jamanetwork.com
Importance Ventricular tachycardia (VT) is associated with high mortality in patients with
cardiac sarcoidosis (CS), and medical management of CS-associated VT is limited by high …

Safety and efficacy of the MitraClip® system for severe mitral regurgitation: A Systematic Review

K Vakil, H Roukoz, M Sarraf, B Krishnan… - Catheterization and …, 2014 - Wiley Online Library
Background The MitraClip ® system is a newer percutaneous device that has shown
promising results but data on its safety and efficacy in low‐ and high‐surgical risk populations …

Cardiovascular magnetic resonance imaging phenotypes and long-term outcomes in patients with suspected cardiac sarcoidosis

…, AC Elton, J Markowitz, L von Wald, H Roukoz… - JAMA …, 2022 - jamanetwork.com
Importance In patients with sarcoidosis with suspected cardiac involvement, late gadolinium
enhancement (LGE) on cardiovascular magnetic resonance imaging (CMR) identifies those …